CKDinform: Early Detection and Prevention

Fairfax, VA US
October 29, 2016

This 3-hour CME/CE symposium focuses on the unique role that primary care practitioners (PCPs) play in managing CKD patients. The burden of CKD to the population, modifiable CKD risk factors, screening methods, and interpretation of test results will be discussed. The use of GFR and albuminuria in CKD detection will also be covered. Evidence-based treatment recommendations and management plans for CKD will be presented. This program will also address the need for timely referral to nephrologists, in addition to the importance of patient education and counseling. Case-based questions are also included.

PLEASE NOTE: YOU MUST LOGIN OR CREATE AN ACCOUNT BEFORE REGISTERING FOR THIS EDUCATIONAL ACTIVITY. 

Once you are logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target Audience

  • Physicians
  • Family Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Nurses
  • Other clinicians who care for people with CKD
Agenda:
8:00am - 8:45amBreakfast and Registration (in the Atrium)
8:45am - 9:00amWelcome
9:00am - 10:00am

CKDinform: Early Detection and Prevention
A Primary Care Approach to CKD Management

Gretchen Brandt, MD - Kaiser Permanente

Upon completion of this activity, learners will be better able to:

  • Identify timely testing and intervention strategies in patients at-risk for chronic kidney disease (CKD).
  • Explain appropriate clinical measures to manage risk and increase patient safety in CKD.
  • Recognize co-management and referral of patients to nephrology specialists, when appropriate, in order to improve outcomes in CKD.
10:00am - 10:15amBreak
10:15am - 11:15am

CKDinform: Early Detection and Prevention
A PCP’s Guide to CKD Detection and Delaying Progression

Jeffrey Kopp, MD - NIH NIDDK

Upon completion of this activity, learners will be better able to:

  • Describe suitable screening tools, such as GFR and ACR for proper utilization in clinical practice related to the diagnosis and monitoring of CKD.
  • Define and classify CKD, based on GFR and albuminuria categories, in order to guide appropriate treatment approaches.
  • Recognize evidence-based management strategies that will help delay CKD progression in at-risk patients and improve outcomes.
11:15am - 12:15pm

CKDinform: Early Detection and Prevention
Renal Replacement Therapy: What the PCP Needs to Know

Tulsi Mehta, MD, FASN - Medical Faculty Associates

Upon completion of this activity, learners will be better able to:

  • Describe treatment options for renal replacement therapy to improve awareness and understanding.
  • Explain evidence-based strategies to manage patients with kidney failure in need of renal replacement therapy to improve outcomes.
  • Discuss management of patients receiving dialysis or living with a kidney transplant, from a primary care perspective.
12:15pm - 12:30pm

Questions & Answers / Closing Remarks

Accreditation/Designation of Credit Information:

Physician

The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Kidney Foundation designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

This Live activity, CKDinform: Early Detection and Prevention, with a begin date of 03/31/2016, has been reviewed and is acceptable for up to 3.0 Prescribed and 0.0 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistant

AAPA accepts certificates of participation for educational activities certified for Category I credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner

This program is approved for 3.0 contact hours of continuing education (which includes 0.53 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 160221207.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.  

Nurse

The National Kidney Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 3.0 contact hours of continuing nursing education (includes 0.53 contact hours in the area of pharmacology). 

Method of Participation:

Participants will attend the live symposia and submit an online evaluation.  Participants will be able to download their certificate upon completion of the online evaluation.  Credits will be awarded based on sessions attended.


This activity is supported by educational grants from AMAG Pharmaceuticals, Inc., AstraZeneca, Mallinckrodt Pharmaceuticals, and Sanofi US.


For more information, contact:

Ken Balla
kenneth.balla@kidney.org
202.244.7900 ext. 701

Course summary
Available credit: 
  • 3.00 AAFP Prescribed Credits
  • 3.00 AANP Contact Hours
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC Nurse Contact Hours
  • 0.53 AANP Pharmacology
  • 0.53 ANCC Pharmacology
  • 3.00 Attendance
  • 3.00 Category I Credit for Physician Assistants
Course opens: 
08/17/2016
Course expires: 
12/30/2016
Event starts: 
10/29/2016 - 8:00am
Event ends: 
10/29/2016 - 12:30pm
Cost:
$25.00
Rating: 
4
Inova Center for Personalized Health
3255 Gallows Road
Fairfax, VA 22037
United States

Available Credit

  • 3.00 AAFP Prescribed Credits
  • 3.00 AANP Contact Hours
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 ANCC Nurse Contact Hours
  • 0.53 AANP Pharmacology
  • 0.53 ANCC Pharmacology
  • 3.00 Attendance
  • 3.00 Category I Credit for Physician Assistants

Accreditation Period

Course opens: 
08/17/2016
Course expires: 
12/30/2016

Price

Cost:
$25.00
Please login or register for a PERC account to take this course.